Sodium iodide I-131 (Iodine 131) is radioactive iodine that is used to treat a variety of thyroid-related disorders including graves disease and thyroid cancers.

Sodium Iodate (Iodine 131) Uses:

• Diagnostic agent:

  • Iodine 131 is used for the radioactive iodine (RAI) uptake test to evaluate thyroid function and for thyroid imaging.
  • Note: Due to increased thyroid radiation exposure with sodium iodide, alternative agents such as sodium iodide I-123, technetium-99m pertechnetate are recommended for routine thyroid scintigraphy

• Therapeutic agent:

  • It is indicated for the management of hyperthyroidism and some of the thyroid malignancies if the lesions take up iodide.

• Off Label Use of Sodium iodide, I-131 in Adults:

  • Whole-body imaging for thyroid cancer metastases

Sodium iodide (Iodine 131) dose in adults:

Note: Dose will be expressed as millicuries if dose >1000 microcuries. Radiation safety precautions are necessary during radioactive iodine treatment. Antithyroid medications should be stopped 3 to 4 days before using sodium iodide I-131.

Diagnostic procedures: Oral based on a 70 kg patient:

• Thyroid uptake:

  • 5 to 30 microcuries (or 0.185 to 1.1 megabecquerels) 24 hours before uptake measurement
  • maximum dose of 10 microcuries (0.37 megabecquerels)

• Dose adjustment if used in conjunction with technetium Tc 99m sodium pertechnetate:

  • 4 to 5 microcuries (0.15 to 0.185 megabecquerels) .

Iodine 131 Dose in the Thyroid imaging:

• 50 to 100 microcuries (or 1.85 to 3.7 megabecquerels) 16 to 24 hours before imaging.

Iodine 131 Dose in the Whole-body imaging for thyroid cancer metastases (off-label):

• 1 to 5 millicuries (37 to 185 megabecquerels) 24 to 72 hours before imaging.

Sodium iodate (Iodine 131) dose in the treatment of Hyperthyroidism:

• Manufacturer's labeling recommends 4 to 10 millicuries (or 148 to 370 megabecquerels) but it has high failure rates.

Sodium iodate (Iodine 131) dose in the treatment of Graves’ disease:

• 10 to 15 millicuries (or 370 to 555 megabecquerels) or 150 microcuries/g of tissue corrected for 24-hour radioactive iodine uptake.

Sodium Iodate (Iodine 131) dose in the treatment of Toxic multinodular goiter (off-label dosing):

• 150 to 200 microcuries/g of tissue corrected for 24-hour radioactive iodine uptake (see dose equation below), if hyperthyroidism persists, may repeat after 6 months if needed

Sodium Iodate (Iodine 131) dose in the treatment of Toxic thyroid adenoma (off-label dosing):

• 10 to 20 millicuries (or 370 to 740 megabecquerels) or 150 to 200 microcuries/g of tissue corrected for 24-hour radioactive iodine uptake, if hyperthyroidism persists, may repeat after 6 months if needed
• Dose equation corrected for 24-hour radioactive iodine uptake:
  • Activity (millicuries) = (gland weight in grams x desired dose in microcuries/gram x [1/24 hour uptake in % of dose])/1,000

Sodium Iodate (Iodine 131) dose in the treatment of Thyroid cancer:

• Ablation of normal thyroid tissue:

  • Initial: 30 to 100 millicuries (or 1,100 to 3,700 megabecquerels).

Note: 150 millicuries is advised for initial adjuvant therapy in microscopic residual disease without metastasis.

• Subsequent metastases ablation:

  • 100 to 200 millicuries (or 3,700 to 7,400 megabecquerels)

Sodium iodide (iodine 131) dose in children with Graves Disease:

• Children ≥5 years of age:

  • Oral: Dose is dependent upon gland size;
  • >150 microcuries/gm of thyroid tissue is necessary to induce hypothyroidism;
  • if the gland is between 50 to 80 gms, higher activities (200 to 300 microcuries/g of thyroid tissue) may be needed.
  • Therapy in children between 5 to 10 years of age is acceptable if the calculated dose is <10 millicuries

Pregnancy Risk Factor X

• It crosses the placenta and can cause irreversible neonatal hypothyroidism. Therefore, it is not recommended during pregnancy.
• Both males and females should use two effective contraceptives during treatment. They are both recommended for at least one year.
• It is best to delay elective diagnostic procedures until after delivery.

Sodium iodide I-131 use during breastfeeding:  

• Iodine-131 can be found in breast milk. Therefore, it is not recommended that you breastfeed or pump for at least 4 weeks before taking sodium iodide I.
• If sodium iodide Iodide has been given after delivery, breastfeeding should be avoided
• It is important to delay elective diagnostic procedures until after breastfeeding has stopped.

Sodium iodide (Iodine 131) dose adjustment in renal disease:

• There are no dosage adjustments provided in manufacturer's labeling.
• However reduced clearance and increased radiation exposure is observed in renal impairment.
• Hemodialysis: Sodium iodide I is dialyzable.

Sodium iodide (Iodine 131) dose adjustment in liver disease:

There are no dosage adjustments provided in manufacturer's labeling.

Side effects of Sodium iodide (Iodine 131):

• Cardiovascular:

  • Chest Pain
  • Tachycardia

• Central Nervous System:

  • Cerebral Edema (In Patients With Iodine-Avid Brain Metastases)
  • Headache

• Dermatologic:

  • Pruritus
  • Skin Lesion (Iododerma)
  • Skin Rash
  • Urticaria

• Endocrine & Metabolic:

  • Goiter
  • Hyperthyroidism
  • Hypoparathyroidism
  • Hypothyroidism
  • Ovarian Failure (Transient)
  • Thyroid Storm

• Gastrointestinal:

  • Gastritis
  • Nausea
  • Salivary Gland Disease
  • Sialadenitis
  • Sore Throat
  • Vomiting
  • Xerostomia

• Genitourinary:

  • Inhibition Of Testicular Function (Transient)

• Hematologic & Oncologic:

  • Anemia
  • Bone Marrow Depression
  • Hematologic Abnormality
  • Leukemia
  • Leukopenia
  • Neoplasm
  • Solid Tumor
  • Thrombocytopenia

• Hepatic:

  • Hepatic Insufficiency

• Hypersensitivity:

  • Hypersensitivity Reaction

• Local:

  • Local Pain (Pain On Swallowing)
  • Local Swelling (Thyroid Or Site Of Iodide Avid Tumor)
  • Localized Tenderness

• Ophthalmic:

  • Conjunctivitis
  • Epiphora
  • Lacrimal Duct Obstruction (Dacryostenosis)
  • Lacrimal Dysfunction
  • Xerophthalmia

• Respiratory:

  • Bronchospasm
  • Cough
  • Pulmonary Fibrosis (In Patients With Iodine-Avid Lung Metastases)
  • Radiation Pneumonitis (In Patients With Iodine-Avid Lung Metastases)

• Miscellaneous:

  • Radiation Injury (Including Radiation Sickness)

Contraindication to Sodium iodide I-131 (Iodine 131):

• Diarrhea and vomiting
• Breastfeeding and Pregnancy
• Concurrent antithyroid medication (discontinue 3-4 days before administration).
• Treatment of thyroid malignancies without iodide uptake, such as anaplastic and medullary carcinomas

Warnings and precautions

• Hypersensitivity

  • Sodium Iodide I solution could contain sodium bisulfite. This sulfite can cause anaphylactic reactions, fatal asthmatic episodes, and allergic-type reactions.

• Infertility

  • Transient,dose-related testicular impairment in males and ovarian failure in females after sodium iodide is seen.

• Radiation-induced thyroiditis

  • Thyroiditis can be caused by sodium iodide I. This can lead to hyperthyroidism that may become more severe.
  • To reduce the chance of thyroid storm and hyperthyroidism, beta-blocker therapy should be used before I use sodium iodide.

• Radiation toxicities

  • These include salivary gland and lacrimal toxicity that presents as conjunctivitis and epiphora.
  • There is an increased risk of neoplasia, hematopoietic suppression and transient neutropenia/thrombocytopenia.

• Thyroid-stimulating Hormone/thyroid Enlargement

  • Thyroid enlargement can lead to obstruction of the trachea or esophagus.

• Graves orbitopathy

  • Patients with Graves orbitopathy are not advised to receive radioactive iodine therapy.
  • Radioactive iodine therapy (RAI) is only indicated for active/mild diseases.
  • A combination of glucocorticoids may be required in cases of high thyrotropin receptor antibody and smoking. This can lead to orbitopathy.

• Hyperthyroidism/thyrotoxic cardiac disease:

  • Radiation thyroiditis can sometimes be exacerbated. This can be prevented by antithyroid drugs and/or beta-blockers prior to and after treatment.

• Hypochloremia:

  • May increase thyroid uptake sodium iodide I and 131.

• Renal impairment

  • Nephrosis can increase thyroid uptake sodium iodide I and 131.

Sodium iodide I-131: Drug Interaction

Note: Drug Interaction Categories:

• Risk Factor D: Consider Treatment Modification
• Risk Factor X: Avoid Concomitant Use

Monitoring parameters:

Thyroid function tests (TSH, free T4, free T3, and total T4 and T3 ) 1-2 months after the treatment and at 4 -6 week intervals for 6 months, or until hypothyroid and stable on thyroid hormone replacement (Graves’ disease, toxic multinodular goiter, and toxic adenoma)

Hair Removing Hard Beans Wax Painless Beauty Wax Beans For All Skins Wax Beans For Face Body Legs

How to administer Sodium iodide I-131 (Iodine 131)?

Proper hydration before treatment and radiation safety precautions are recommended.

Hicon:

• The solution should be diluted before use and kept in a shielded container with a straw. It should be given on an empty stomach.
• The patient should fast at least 2 hours before and 2 hours after administration to ensure adequate absorption.

Radiopharmaceutical:

• Use appropriate precautions for handling and disposal. Waterproof gloves should be worn while handling and administering sodium iodide I131.

Mechanism of action of Sodium iodide I-131 (iodine 131):

• The body's extracellular fluid is able to absorb and distribute sodium iodide quickly. 
• The thyroid is the site of concentration of iodide via the sodium/iodide portaler. It is then oxidized to Iodine by beta emission.

Absorption: Oral: Rapidly (90% within 60 minutes)

Distribution: Extracellular space; primarily trapped by the thyroid gland.

Protein binding: None

Metabolism: Iodide is rapidly oxidized to iodine in the thyroid

Excretion: Urine (37% to 75%), feces 10%

International Brands of Sodium iodide I-131:

• Draximage

Sodium iodide I-131 brand names in Pakistan:

Brands will be updated later.